Celyad SA Performance
| CYADDelisted Stock | USD 0.52 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.41, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Celyad SA's returns are expected to increase less than the market. However, during the bear market, the loss of holding Celyad SA is expected to be smaller as well. Celyad SA right now shows a risk of 0.0%. Please confirm Celyad SA jensen alpha, potential upside, rate of daily change, as well as the relationship between the treynor ratio and expected short fall , to decide if Celyad SA will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Celyad SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Celyad SA is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 30 M |
Celyad |
Celyad SA Relative Risk vs. Return Landscape
If you would invest 52.00 in Celyad SA on November 2, 2024 and sell it today you would earn a total of 0.00 from holding Celyad SA or generate 0.0% return on investment over 90 days. Celyad SA is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Celyad, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Celyad SA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Celyad SA's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Celyad SA, and traders can use it to determine the average amount a Celyad SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CYAD |
Based on monthly moving average Celyad SA is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Celyad SA by adding Celyad SA to a well-diversified portfolio.
Celyad SA Fundamentals Growth
Celyad Stock prices reflect investors' perceptions of the future prospects and financial health of Celyad SA, and Celyad SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Celyad Stock performance.
| Return On Equity | -1.71 | |||
| Return On Asset | -0.25 | |||
| Current Valuation | (1.57 M) | |||
| Shares Outstanding | 22.59 M | |||
| Price To Earning | (22.08) X | |||
| Price To Book | 0.69 X | |||
| Price To Sales | 12,738 X | |||
| EBITDA | (18.81 M) | |||
| Cash And Equivalents | 14.38 M | |||
| Cash Per Share | 0.64 X | |||
| Total Debt | 255 K | |||
| Debt To Equity | 0.07 % | |||
| Book Value Per Share | 0.19 X | |||
| Cash Flow From Operations | (28.01 M) | |||
| Earnings Per Share | (1.47) X | |||
| Total Asset | 19.72 M | |||
| Retained Earnings | (349.95 M) | |||
| Current Asset | 118.86 M | |||
| Current Liabilities | 12.48 M | |||
About Celyad SA Performance
By analyzing Celyad SA's fundamental ratios, stakeholders can gain valuable insights into Celyad SA's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Celyad SA has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Celyad SA has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T cell therapies for the treatment of cancer. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium. Celyad Sa operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 95 people.Things to note about Celyad SA performance evaluation
Checking the ongoing alerts about Celyad SA for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Celyad SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Celyad SA is not yet fully synchronised with the market data | |
| Celyad SA has some characteristics of a very speculative penny stock | |
| Celyad SA has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (40.94 M) with profit before overhead, payroll, taxes, and interest of 5 K. | |
| Celyad SA currently holds about 14.38 M in cash with (28.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.64, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Celyad SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Celyad SA's stock is overvalued or undervalued compared to its peers.
- Examining Celyad SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Celyad SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Celyad SA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Celyad SA's stock. These opinions can provide insight into Celyad SA's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Celyad Stock
If you are still planning to invest in Celyad SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Celyad SA's history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |